The following adjustment was made today on Novartis (NVS). All prices include IB commissions.
This is the second position on NVS.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 10 |
| Fair Value Estimate | $71.00 |
| Target Buy Price | $56.80 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $52.50 |
| Actual Margin of Safety | 26.06% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 3/22/2012 | NVS | Continued Trade | STO 1 May12 52.50 Put @ 0.51 | $50.72 |
Current Position Summary
| Cost Basis | ($5,250.00) |
| Income Generated | $168.69 |
| Percent Income Generated | 3.21% |
| Annualized Income Generated | 10.29% |
| Net Profit If Assigned | $168.69 |
| Percent Return If Assigned | 3.21% |
| Annualized Return If Assigned | 10.29% |
| Days Held to Expiration | 114 days |
Trade History
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 1/25/2012 | NVS | CSP Margin Used | CSP 100 NVS @ 52.50 | ($5,250.00) | ||
| 1/25/2012 | NVS | Initial Put Option | STO 1 Mar12 52.50 Put @ 1.18 | Expired | $117.97 | |
| 3/22/2012 | NVS | Continued Trade | STO 1 May12 52.50 Put @ 0.51 | $50.72 | ||
| 5/18/2012 | NVS | Totals | ($5,250.00) | $168.69 | ||
| DTE | 114 | Percent Income/Annualized | 3.21% | 10.29% |
